World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

EBOS Group is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of recognized consumer products and animal care brands.

EBOS Group has over 3,700 employees and 61 locations across Australia and New Zealand.

ORPEA SA is a healthcare services providing company The headquarters is in France.

NuVasive is a Healthcare company. It is estimated 10 million U.S. adults suffer from chronic back pain each year which creates the third highest spend in U.S. healthcare. The company support includes online learning ,live clinical observation, case support and peer education. The headquarters is in USA.

In 2019, they achieved 1.168 billion USD in full-year revenue and it has 2,800 employees.

Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services, Information Management, Real Estate and Glass Packaging. The Group has offices in over 30 countries and a global brand presence in more than 100 markets. Headquarters is in Mumbai of India.

Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.